The Evolving Challenges of Targeting PI3K in Breast Cancer
March 13th 2015Josh D. Lauring, of Johns Hopkins Medicine, is interested in identifying the genetic changes that drive breast cancer growth in order to determine novel therapeutic targets for drug development and ultimately improve outcomes for patients with breast cancer.
Read More